학술논문
312 LOW DOSE DOUBLE EPIGENETIC THERAPY IMPROVES IMMUNOTHERAPY RESPONSE AND PROLONGS SURVIVAL IN PANCREATIC CANCER.
Document Type
Article
Source
Gastroenterology (00165085); 2024 Supplement, Vol. 166 Issue 5, pS-67-S-67, 1p
Subject
Language
ISSN
00165085